Literature DB >> 25711272

Tsukamurella inchonensis infection in a child with Hodgkin's lymphoma.

Fumihiro Ochi1, Hisamichi Tauchi, Kyoko Moritani, Hitoshi Miyamoto, Kiyofumi Ohkusu, Eiichi Ishii.   

Abstract

Tsukamurella spp. infection is a rare but important cause of bacteremia in immunocompromised patients. The organism is an aerobic, Gram-positive, weakly acid-fast bacillus that is difficult to differentiate from other aerobic Actinomycetales by standard laboratory methods. Here, we report on the case of a 14-year-old patient with Hodgkin's lymphoma who, after intensive chemotherapy, developed Tsukamurella inchonensis bacteremia, which was identified on the peripherally inserted central venous catheter (PICC) using 16S rRNA sequencing analysis. The bacteremia was successfully controlled with antimicrobial therapy and subsequent removal of the PICC. This is the first report of bacteremia by Tsukamurella inchonensis in immunocompromised children. Careful observation and prompt analysis of opportunistic infection, including Tsukamurella spp., is very important in immunocompromised children.
© 2015 Japan Pediatric Society.

Entities:  

Keywords:  Hodgkin's lymphoma; Tsukamurella inchonensis; bacteremia; catheter-related bloodstream infection; central venous catheters

Mesh:

Year:  2015        PMID: 25711272     DOI: 10.1111/ped.12472

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  2 in total

1.  Bacterial Peritonitis Caused by Tsukamurella inchonensis in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis.

Authors:  Ling Tang; Ying Huang; Tingting Li; Yajuan Li; Yuanhong Xu
Journal:  Infect Drug Resist       Date:  2022-05-12       Impact factor: 4.177

2.  Structural elucidation of Tsukamurella pulmonis neutral polysaccharide and its visualization in infected mouse tissues by specific monoclonal antibodies.

Authors:  Adnan Saeed; Mariola Paściak; Sabina Górska; Ireneusz Ceremuga; Elżbieta Gamian; Piotr Ziółkowski; Marek Drab; Andrzej Gamian
Journal:  Sci Rep       Date:  2018-08-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.